Cosmos Health Inc. (COSM) CEO converts $70K debt into new shares

Rhea-AI Filing Summary

Cosmos Health Inc. CEO Grigorios Siokas converted $70,000 of company debt into 168,472 shares of common stock on December 15, 2025. The shares, described as Exchange Shares under a Debt Exchange Agreement between Siokas and the company, were issued at $0.4155 per share, identified as the fair market value of the stock on that date.

After this transaction, Siokas directly beneficially owned 6,628,457 Cosmos Health common shares. He is listed as a director, chief executive officer, and a more than 10% owner of Cosmos Health Inc.

Insider Trade Summary

Net Buyer: 168,472 shares

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 168,472 shs ($70K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	168,472	$0.4155	$70K

Holdings After Transaction: Common Stock, par value $.001 — 6,628,457 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of December 15, 2025, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.4155 per share, the fair market value of the Common Stock on December 15, 2025, in exchange for a total amount of $70,000 in debt the Company owed to Mr. Siokas.

FAQ

What insider transaction did Cosmos Health Inc. (COSM) report for December 15, 2025?

Cosmos Health Inc. reported that CEO Grigorios Siokas acquired 168,472 shares of common stock on December 15, 2025 through a debt-for-equity exchange.

How much company debt did the Cosmos Health (COSM) CEO exchange for shares?

Grigorios Siokas exchanged $70,000 of debt that Cosmos Health Inc. owed him for 168,472 common shares under a Debt Exchange Agreement.

At what price per share were the new Cosmos Health (COSM) shares issued to the CEO?

The Exchange Shares were issued at $0.4155 per share, which the agreement identifies as the fair market value of Cosmos Health common stock on December 15, 2025.

How many Cosmos Health (COSM) shares does CEO Grigorios Siokas own after this transaction?

Following the reported transaction, Grigorios Siokas directly beneficially owned 6,628,457 shares of Cosmos Health Inc. common stock.

What is the relationship of Grigorios Siokas to Cosmos Health Inc. (COSM)?

Grigorios Siokas is listed as a director, chief executive officer, and a 10% owner of Cosmos Health Inc.

Was the Cosmos Health (COSM) CEO’s share acquisition an open-market purchase?

No. The shares were acquired as Exchange Shares under a Debt Exchange Agreement, where company debt owed to Grigorios Siokas was exchanged for common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/16/2025 - 12:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR

PILEA

(Street)

THESSALONIKI J3 TK57001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	12/15/2025	12/15/2025	P(1)		168,472	A	$0.4155	6,628,457	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of December 15, 2025, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.4155 per share, the fair market value of the Common Stock on December 15, 2025, in exchange for a total amount of $70,000 in debt the Company owed to Mr. Siokas.

Remarks:

	/s/ Grigorios Siokas	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.